We are live on ! Find out more
KLDO

Kaleido Biosciences, Inc. Common Stock
KLDO

Delisted

KLDO was delisted on the 14th of April, 2022.

Back to rankings

3 hedge funds and large institutions have $0 invested in Kaleido Biosciences, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 2 → 3 (+1)

100% less capital invested

Capital invested by funds: $2 → $0 (-$2)

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

KLDO Hedge Fund Activity: Q2 2025 in Review

3 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Kaleido Biosciences, Inc. Common Stock (KLDO) for Q2 2025, worth a combined $0 — down 100% from $2 a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new KLDO positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 3 institutional investors held Kaleido Biosciences, Inc. Common Stock (KLDO) as of Q2 2025, up from 2 in Q1 2025.
  • Funds reported $0 of Kaleido Biosciences, Inc. Common Stock stock for Q2 2025, down 100% quarter-over-quarter.
  • 1 fund opened new Kaleido Biosciences, Inc. Common Stock positions in Q2 2025 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q2 2025.